{"title":"精氨酸加压素与人胎儿急性血管内容量扩张的关系。","authors":"C P Weiner, F Smith, J E Robillard","doi":"10.1159/000263425","DOIUrl":null,"url":null,"abstract":"<p><p>There is presently no information concerning the ontogeny and control of arginine vasopressin (AVP) in the human fetus. AVP was measured in 22 nonanemic control fetuses and 7 fetuses with hemolytic anemia undergoing 13 intravascular transfusions. Each transfused fetus received pancuronium (0.3 mg/kg) and furosemide (2 mg/kg). Compared to the control group of nonanemic fetuses with hemolytic disease, AVP was significantly lower in the anemic fetus prior to transfusion (2.6 +/- 0.4 microU/ml versus 10.4 +/- 4.1 microU/ml, p less than 0.05). This suggests that hemolytic anemia is associated with a relative increase in fetal intravascular volume. Intravascular transfusion was associated with a significant increase in AVP (p less than 0.05). These findings could not be explained by changes in either blood pressure, plasma osmolality, or fetal oxygenation.</p>","PeriodicalId":77713,"journal":{"name":"Fetal therapy","volume":"4 2-3","pages":"69-72"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000263425","citationCount":"6","resultStr":"{\"title\":\"Arginine vasopressin and acute, intravascular volume expansion in the human fetus.\",\"authors\":\"C P Weiner, F Smith, J E Robillard\",\"doi\":\"10.1159/000263425\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>There is presently no information concerning the ontogeny and control of arginine vasopressin (AVP) in the human fetus. AVP was measured in 22 nonanemic control fetuses and 7 fetuses with hemolytic anemia undergoing 13 intravascular transfusions. Each transfused fetus received pancuronium (0.3 mg/kg) and furosemide (2 mg/kg). Compared to the control group of nonanemic fetuses with hemolytic disease, AVP was significantly lower in the anemic fetus prior to transfusion (2.6 +/- 0.4 microU/ml versus 10.4 +/- 4.1 microU/ml, p less than 0.05). This suggests that hemolytic anemia is associated with a relative increase in fetal intravascular volume. Intravascular transfusion was associated with a significant increase in AVP (p less than 0.05). These findings could not be explained by changes in either blood pressure, plasma osmolality, or fetal oxygenation.</p>\",\"PeriodicalId\":77713,\"journal\":{\"name\":\"Fetal therapy\",\"volume\":\"4 2-3\",\"pages\":\"69-72\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000263425\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fetal therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000263425\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fetal therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000263425","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
摘要
目前还没有关于精氨酸抗利尿激素(AVP)在人类胎儿中的发生和控制的信息。对22例无贫血对照胎儿和7例溶血性贫血胎儿进行13次血管内输血,测量AVP。每个输血的胎儿给予泮库溴铵(0.3 mg/kg)和呋塞米(2 mg/kg)。与溶血性疾病的非贫血胎儿对照组相比,输血前贫血胎儿AVP显著降低(2.6 +/- 0.4微u /ml vs 10.4 +/- 4.1微u /ml, p < 0.05)。这表明溶血性贫血与胎儿血管内体积的相对增加有关。血管内输血与AVP显著升高相关(p < 0.05)。这些发现不能用血压、血浆渗透压或胎儿氧合的变化来解释。
Arginine vasopressin and acute, intravascular volume expansion in the human fetus.
There is presently no information concerning the ontogeny and control of arginine vasopressin (AVP) in the human fetus. AVP was measured in 22 nonanemic control fetuses and 7 fetuses with hemolytic anemia undergoing 13 intravascular transfusions. Each transfused fetus received pancuronium (0.3 mg/kg) and furosemide (2 mg/kg). Compared to the control group of nonanemic fetuses with hemolytic disease, AVP was significantly lower in the anemic fetus prior to transfusion (2.6 +/- 0.4 microU/ml versus 10.4 +/- 4.1 microU/ml, p less than 0.05). This suggests that hemolytic anemia is associated with a relative increase in fetal intravascular volume. Intravascular transfusion was associated with a significant increase in AVP (p less than 0.05). These findings could not be explained by changes in either blood pressure, plasma osmolality, or fetal oxygenation.